Growth Metrics

Regeneron Pharmaceuticals (REGN) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.32%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -10.19%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 24.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.92%
10 Revolution Medicines 31.20 Bn 31.20 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12.18%
Dec 31, 2025 11.32%
Sep 30, 2025 12.68%
Jun 30, 2025 12.42%
Mar 31, 2025 11.09%
Dec 31, 2024 10.93%
Sep 30, 2024 10.81%
Jun 30, 2024 9.77%
Mar 31, 2024 8.88%
Dec 31, 2023 10.19%
Sep 30, 2023 8.15%
Jun 30, 2023 7.83%
Mar 31, 2023 9.12%
Dec 31, 2022 8.06%
Sep 30, 2022 9.09%
Jun 30, 2022 8.31%
Mar 31, 2022 9.01%
Dec 31, 2021 8.09%
Sep 30, 2021 8.20%
Jun 30, 2021 10.79%
Mar 31, 2021 10.80%
Dec 31, 2020 11.46%
Sep 30, 2020 13.24%
Jun 30, 2020 13.26%
Mar 31, 2020 12.70%
Dec 31, 2019 12.21%
Sep 30, 2019 9.78%
Jun 30, 2019 8.73%
Mar 31, 2019 9.11%
Dec 31, 2018 9.21%
Sep 30, 2018 10.99%
Jun 30, 2018 8.84%
Mar 31, 2018 5.17%
Dec 31, 2017 13.21%
Sep 30, 2017 21.49%
Jun 30, 2017 27.57%
Mar 31, 2017 36.64%
Dec 31, 2016 30.69%
Sep 30, 2016 26.92%
Jun 30, 2016 33.69%
Mar 31, 2016 50.04%
Dec 31, 2015 63.62%
Sep 30, 2015 80.12%
Jun 30, 2015 87.48%
Mar 31, 2015 84.83%
Dec 31, 2014 84.88%
Sep 30, 2014 80.43%
Jun 30, 2014 68.55%
Mar 31, 2014 53.13%
Dec 31, 2013 38.70%
Sep 30, 2013 21.71%
Jun 30, 2013 12.73%
Mar 31, 2013 6.06%
Dec 31, 2012 3.26%
Sep 30, 2012 2.47%
Jun 30, 2012 2.87%
Mar 31, 2012 3.51%
Dec 31, 2011 5.90%
Sep 30, 2011 14.26%
Jun 30, 2011 23.79%
Dec 31, 2010 33.80%